Science and Technology Commercialization //

Patent of the Week: Helping AI Systems Multitask and Remember

An artificial neural network (ANN) is a computer program designed to operate similarly to the human brain and the ways in which it processes information. However, while the brain…
News //

Patent of the Week: Eliminating Trial and Error for a Better Biopsy

University of Chicago Medicine doctor Seon-Kyu Lee has patented a novel surgical mallet design that enables biopsy needles to be positioned in place and imaged simultaneously. Surgical biopsy needles…
News //

Patent of the Week: Selectively Stimulating Cells for Pain Treatment, Immunotherapy

Many diseases, including Parkinson's and irregular heartbeat, can be treated by electrically stimulating organs using an implantable device. However, the use of these devices is often high risk, as…
News //

Patent of the Week: Boosting the Microbiome to Prevent Infection

Many antibiotic-resistant infections in humans can be traced to food and animals due to the widespread use of antibiotics on farms. Because of this, there is an urgent need…
Science and Technology Commercialization //

Patent of the Week: In Search of a Universal Flu Vaccine

University of Chicago researchers, including Patrick Wilson, PhD, professor of medicine, UChicago Biological Sciences Division, have filed a patent for a panel of antibodies that neutralize a range of…
News //

Patent of the Week: Treating, Preventing Bacterial Infections

Every year, at least 2.8 million people in the US get an antibiotic-resistant infection – and more than 35,000 people die, according to the CDC. In this week’s featured…
News //

Patent of the Week: Improving the Performance of Antibody Fragments

Antibody fragments, including Fabs, which bind to immune response-triggering substances, or antigens, have demonstrated utility in various research and diagnostic applications. However, their structure limits their use, so researchers…
News //

Patent of the Week: Increased Safety and Improved Protection of Vaccines

Researchers, including Aaron Esser-Kahn, an associate professor at UChicago’s Pritzker School of Molecular Engineering, have filed a patent application for a novel additive that limits undesirable vaccine-related side effects.…
Science and Technology Commercialization //

Patent of the Week: A Specialized Antibody Library to Accelerate Drug Development

Researchers have developed a highly-optimized recombinant antibody phage-display library to accelerate drug development.
Science and Technology Commercialization //

Patent of the Week: Targeting the Treatment of Inflammatory Diseases

A biologic drug delivery platform targets the treatment of inflammatory diseases by honing in on collagen exposed by inflammation. “Enhancing the therapeutic efficacy of drugs for inflammatory diseases is…
News //

Patent of the Week: Creating a Temperature-Stable Vaccine Platform

Researchers have developed a novel vaccine platform with fewer side-effects and shelf-stability, which addresses the significant challenge of distributing vaccines to developing countries.
Science and Technology Commercialization //

Patent of the Week: Enhancing Vaccine Efficiency

Researchers at the Pritzker School of Molecular Engineering at the University of Chicago developed a new platform technology for improving the efficiency of vaccines. Jeffrey Hubbell, Eugene Bell Professor…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept